Related references
Note: Only part of the references are listed.Physico-chemical parameters that govern nanoparticles fate also dictate rules for their molecular evolution
Sandrine Dufort et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Repeated injections of PEGylated liposomal topotecan induces accelerated blood clearance phenomenon in rats
Yanling Ma et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging
Suphiya Parveen et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2012)
Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents
R. Dinarvand et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2011)
SIMPLE AND EFFICIENT HPLC-UV QUANTITATION OF ETOPOSIDE AND ITS CIS-ISOMER IN RAT MICRO-VOLUME PLASMA AND TISSUE SAMPLES: APPLICATION TO PHARMACOKINETIC AND BIODISTRIBUTION STUDIES
Roonak Saadati et al.
JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES (2011)
Evasion of the Accelerated Blood Clearance Phenomenon by Coating of Nanoparticles with Various Hydrophilic Polymers
Tsutomu Ishihara et al.
BIOMACROMOLECULES (2010)
Effects of cleavable PEG-cholesterol derivatives on the accelerated blood clearance of PEGylated liposomes
Huan Xu et al.
BIOMATERIALS (2010)
Effect of polyethylene glycol (PEG) chain organization on the physicochemical properties of poly(D, L-lactide) (PLA) based nanoparticles
Sherief Essa et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2010)
Repeated injection of pegylated liposomal antitumour drugs induces the disappearance of the rapid distribution phase
JingXia Cui et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2010)
Accelerated Blood Clearance Was Not Induced for a Gadolinium-Containing PEG-poly(L-lysine)-Based Polymeric Micelle in Mice
Huili Ma et al.
PHARMACEUTICAL RESEARCH (2010)
Hemoglobin Vesicles, Polyethylene Glycol (PEG)ylated Liposomes Developed as a Red Blood Cell Substitute, Do Not Induce the Accelerated Blood Clearance Phenomenon in Mice
Kazuaki Taguchi et al.
DRUG METABOLISM AND DISPOSITION (2009)
Effect of siRNA in PEG-coated siRNA-lipoplex on anti-PEG IgM production
Tatsuaki Tagami et al.
JOURNAL OF CONTROLLED RELEASE (2009)
Paclitaxel-loaded PEGylated PLGA-based nanoparticles: In vitro and in vivo evaluation
Fabienne Danhier et al.
JOURNAL OF CONTROLLED RELEASE (2009)
Accelerated Blood Clearance Phenomenon Upon Repeated Injection of PEG-modified PLA-nanoparticles
Tsutomu Ishihara et al.
PHARMACEUTICAL RESEARCH (2009)
Particle size-dependent triggering of accelerated blood clearance phenomenon
Hiroyuki Koide et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes
Tatsuhiro Ishida et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Frank Alexis et al.
MOLECULAR PHARMACEUTICS (2008)
An open-label study to evaluate dose and cycle dependence of the pharmacokinetics of pegylated liposomal doxorubicin
Alberto Gabizon et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Influence of polymer behaviour in organic solution on the production of polylactide nanoparticles by nanoprecipitation
Philippe Legrand et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2007)
PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner
Tatsuhiro Ishida et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle
Wei Lu et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes
XinYu Wang et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Spleen plays an important role in the induction of accelerated blood clearance of PEGylated liposomes
Tatsuhiro Ishida et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Accelerated blood clearance of PEGylated liposomes upon repeated injections: Effect of doxorubicin-encapsulation and high-dose first injection
Tatsuhiro Ishida et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Accelerated blood clearance of PEGylated liposomes following preceding liposome injection: Effects of lipid dose and PEG surface-density and chain length of the first-dose liposomes
T Ishida et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Effect of the physicochemical properties of initially injected liposomes on the clearance of subsequently injected PEGylated liposomes in mice
T Ishida et al.
JOURNAL OF CONTROLLED RELEASE (2004)
Accelerated clearance of a second injection of PEGylated liposomes in mice
T Ishida et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2003)
Accelerated clearance of PEGylated liposomes in rats after repeated injections
T Ishida et al.
JOURNAL OF CONTROLLED RELEASE (2003)
Polyethylene glycol-liposomal doxorubicin
M Sharpe et al.
DRUGS (2002)
'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG):: influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption
R Gref et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2000)
Share Paper
